Publicaciones (17) Publicaciones en las que ha participado algún/a investigador/a

2019

  1. Acute Intermittent Porphyria: Novel Etiologic and Pathogenic Therapies Based on RNA Transfer to the Liver

    Hepatology

  2. Aging and atrial fibrillation: A matter of fibrosis

    Aging

  3. Author Correction: ‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development (Nature Immunology, (2019), 20, 11, (1409-1413), 10.1038/s41590-019-0503-1)

    Nature Immunology

  4. Blood monitoring of circulating tumor plasma cells by next generation flow in multiple myeloma after therapy

    Blood

  5. Correction to: Methylthioadenosine promotes remyelination by inducing oligodendrocyte differentiation (Multiple Sclerosis and Demyelinating Disorders (2017) 2 (1) DOI: 10.1186/s40893-017-0020-8)

    Multiple Sclerosis and Demyelinating Disorders

  6. Corrigendum to “A Drosophila model of GDAP1 function reveals the involvement of insulin signalling in the mitochondria-dependent neuromuscular degeneration” [Biochim. Biophys. Acta 1863 (2017) 801–809](S0925443917300078)(10.1016/j.bbadis.2017.01.003)

    Biochimica et Biophysica Acta - Molecular Basis of Disease

  7. Erratum: Correction to: SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF (Journal of experimental & clinical cancer research : CR (2019) 38 1 (172))

    Journal of experimental & clinical cancer research : CR

  8. Erratum: Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience (PLoS ONE (2019)14:6 (e0217881)Doi:10.1371/journal.pone.0217881)

    PLoS ONE

  9. Getting insights into hepatocellular carcinoma tumour heterogeneity by multiomics dissection

    Gut

  10. Identifying New Epigenetic Drivers of Liver Fibrosis

    Cellular and Molecular Gastroenterology and Hepatology

  11. Increased Fibroblast Growth Factor 23 in Heart Failure: Biomarker, Mechanism, or Both?

    American Journal of Hypertension

  12. Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression

    Nature Medicine

  13. New warning signs on the road: 5-hydroxymethylcytosine-based liquid biopsy for the early detection of hepatocellular carcinoma

    Gut

  14. Role of urine immunofixation in defining CR in MM

    Blood

  15. Single-agent venetoclax induces MRD-negative response in relapsed primary plasma cell leukemia with t(11;14)

    American Journal of Hematology

  16. Targeting CCL2/CCR2 in Tumor-Infiltrating Macrophages: A Tool Emerging Out of the Box Against Hepatocellular Carcinoma

    Cellular and Molecular Gastroenterology and Hepatology

  17. ‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development

    Nature Immunology